The adult working years: Common skin findings in sytemic diseases

Clinics in Family Practice

Volumn 5, Issue 3, 2003, Pages 667-689

  Fawcett, Robert S ^a   Stulberg, Daniel L ^b  

^a YORK HOSPITAL   (United States)

^b Utah Valley Fam Pract Resid Prog   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; GENERAL PRACTITIONER; GOOD CLINICAL PRACTICE; HUMAN; PROFESSIONAL PRACTICE; SKIN DISEASE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; WORKER;

EID: 0347407848     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(03)00068-0     Document Type: Review

References (35)

1. Braverman IM. Skin signs in systemic disease. 3rd edition. Philadelphia: WB Saunders; 1998.
2. Bennett WM, et al. The nephropathy of the nail-patella syndrome: clinicopathologic analysis of 11 kindreds. Am J Med 1973;54:304-19.
3. Myers KA, Farquhar DR. Does this patient have clubbing? JAMA 2001;286:341-7.
4. Hussain S, Anderson DN, Salvatti ME, Adamson B, McManus M, Braverman AS. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer 2000; 88:2367-71.
5. Fitzpatrick TB, Johnson RA, Wolff K. Color atlas and synopsis of clinical dermatology. 3rd edition. New York: McGraw-Hill; 1997.
6. Daniel CR. Chronic paronychia and onycholysis: a thirteen-year experience. Cutis 1996;58:397-401.
7. Centers for Disease Control and Council of State and Territorial Epidemiologists. Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(RR10):1-55.
8. Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001;33(12): 2023-7.
9. Rullan E, Sigal LH. Rheumatic fever. Curr Rheumatol Rep 2001;3:445-52.
10. Gable EK, Liu G, Morrell DS. Pediatric exanthems. Prim Care 2000;27:353-69.
11. Hollar CB, Jorizzo JL. Rheumatioid arthritis, rheumatic fever, and gout. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 6th edition. New York: Mosby; 2003. p. 1752.
12. Fritsch PO, Ruiz-Madonado R. Stevens-Johnson syndrome: toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatricks's dermatology in general medicine. 6th edition. New York: Mosby; 2003. p. 545.
13. McKinnon HD, Howard T. Evaluating the febrile patient with a rash. Am Fam Phys 2000;62:804-16.
14. Habif TP, Quitadamo MJ, Campbell JL, Zug KA. Skin disease: diagnosis and treatment. In: Fathman SM, editor. Hypersensitivity syndromes and vasculitis, Chapter 18. St. Louis: Mosby; 2001. p. 576.
15. Kakourou T, Drosatou P, Psychou F, Aroni K, Nicolaidou P. Erythema nodosum in children: a prospective study. J Am Acad Dermatol 2001;44:17-21.
16. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994;30:519-31.
17. Habif TP, Quitadamo MJ, Campbell JL, Zug KA. Skin disease: diagnosis and treatment. In: Fathman SM, editor. Hypersensitivity syndromes and vasculitis, Chapter 15. St. Louis: Mosby; 2001. p. 464-5.
18. Ference BA, Shannon TM, White RI, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994;106:1387-90.
19. Riccardi VM. Neurofibromatosis, past, present and future. New Engl J Med 1991;324: 1283-5.
20. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002;47:789-91.
21. O'Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol 1999;140:283-6.
22. Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 1994;30:236-42.
23. Hsu S, Le EH, Khoshevis MR. Differential diagnosis of annular lesions. Am Fam Phys 2001;64:289-96.
24. English JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001;44:725-43.
25. Holmes CE, Massa M. Skin signs of systemic disease. Postgrad Med 1994;96:94-5.
26. Robson KJ, Piette WW. Cutaneous manifestations of systemic diseases. Med Clin North Am 1998;82:1359-79.
27. Alto WA, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Phys 1999;59:3047-54.
28. Arranz E, Ferguson A. Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology 1993;104:1263-72.
29. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991;80:605-12.
30. Van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11.
31. Koc Y, Gullu I, Akpek G, et al. Vascular involvement in Behcet's disease. J Rheumatol 1992;19:402-10.
32. Lebwohl M. Cutaneous manifestation of systemic diseases. In: Dale DC, editor. Scientific American medicine, Volume 2. New York: Web MD; 2001. p. 4.
33. Levine N, Studdiford J, Young MG. Dermatologic signs of systemic disease. Patient Care 2001. p. 39-53.
34. Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002;87:438-46.
35. Chute CG, Chuang TY, et al. Subsequent risk of internal carcinoma with Bowen's disease. JAMA 1991;266:816-9.